1 |
A somatic activating NRAS variant associated with kaposiform lymphangiomatosis.
20
61
|
Barclay SF...Kurek KC
|
30542204 |
2019 |
2 |
Imaging features of kaposiform lymphangiomatosis.
20
61
|
Goyal P...Chaudry G
|
27053281 |
2016 |
3 |
Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.
61
20
|
Ozeki M...Fukao T
|
26806875 |
2016 |
4 |
Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman.
20
61
|
Safi F...Assaly R
|
24460439 |
2014 |
5 |
Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options.
20
|
Adams DM...Ricci KW
|
31030813 |
2019 |
6 |
Isolated abdominal kaposiform lymphangiomatosis: a novel presentation of a rare entity.
61
|
Chen G...Pang T
|
33036770 |
2021 |
7 |
Kaposiform lymphangiomatosis effectively treated with MEK inhibition.
61
|
Foster JB...Dori Y
|
32894644 |
2020 |
8 |
Kaposiform lymphangiomatosis with spinal involvement.
61
|
Liu SZ...Liu Y
|
31790122 |
2020 |
9 |
Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels.
61
|
Crane J...Le Cras TD
|
32634277 |
2020 |
10 |
Thoracic duct embolization in kaposiform lymphangiomatosis.
61
|
Bundy JJ...Downing T
|
32653407 |
2020 |
11 |
Analysis of mTOR pathway expression in lymphatic malformation and related diseases.
61
|
Hori Y...Morii E
|
32067331 |
2020 |
12 |
Comment on: Potential biomarkers of kaposiform lymphangiomatosis.
61
|
Le Cras TD...Adams DM
|
31872523 |
2020 |
13 |
Reply to: Comment on: Potential biomarkers of kaposiform lymphangiomatosis.
61
|
Ozeki M...Fukao T
|
31930675 |
2020 |
14 |
[Clinical characteristics of Kaposiform lymphangiomatosis: a report of 8 cases].
61
|
Qiu T...Ji Y
|
31826597 |
2019 |
15 |
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis.
61
|
Ozeki M...Fukao T
|
31511039 |
2019 |
16 |
Potential biomarkers of kaposiform lymphangiomatosis.
61
|
Ozeki M...Fukao T
|
31207041 |
2019 |
17 |
Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis.
61
|
Boscolo E...Le Cras TD
|
31045327 |
2019 |
18 |
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
61
|
Ji Y...Li L
|
31277673 |
2019 |
19 |
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
61
|
Ozeki M...Fukao T
|
31196128 |
2019 |
20 |
Generalized Lymphatic Anomaly and Gorham-Stout Disease: Overview and Recent Insights.
61
|
Ozeki M...Fukao T
|
31236308 |
2019 |
21 |
[Our experience with sirolimus for the treatment of complicated vascular anomalies].
61
|
Gimenez-Aleixandre C...Hernandez-Bermejo JP
|
30714698 |
2019 |
22 |
Proliferative Cells From Kaposiform Lymphangiomatosis Lesions Resemble Mesenchyme Stem Cell-like Pericytes Defective in Vessel Formation.
61
|
Glaser K...Dickie BH
|
30256265 |
2018 |
23 |
Pseudotumor cerebri in kaposiform lymphangiomatosis: a case report and pathogenetic hypothesis.
61
|
Barcelo-Lopez C...Martinez-Lage JF
|
29654359 |
2018 |
24 |
Chest imaging in generalized lymphatic anomaly and kaposiform lymphangiomatosis.
61
|
Kato H...Matsuo M
|
29923669 |
2018 |
25 |
MR imaging findings of vertebral involvement in Gorham-Stout disease, generalized lymphatic anomaly, and kaposiform lymphangiomatosis.
61
|
Kato H...Matsuo M
|
28795277 |
2017 |
26 |
Kaposiform Lymphangiomatosis with Human Papillomavirus Infection.
61
|
Radzikowska E...Wiatr E
|
28398067 |
2017 |
27 |
Sirolimus in the Treatment of Vascular Anomalies.
61
|
Triana P...Lopez-Gutierrez JC
|
27723921 |
2017 |
28 |
Angiopoietins as serum biomarkers for lymphatic anomalies.
61
|
Le Cras TD...Adams DM
|
27990590 |
2017 |
29 |
Point-of-Care Thoracic Ultrasonography in the Diagnosis and Management of Kaposiform Lymphangiomatosis.
61
|
Raam MS...Elkhunovich MA
|
27898632 |
2016 |
30 |
Successful treatment of kaposiform lymphangiomatosis with sirolimus.
61
|
Wang Z...Zheng S
|
25598153 |
2015 |
31 |
Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder.
61
|
Fernandes VM...Meier ER
|
25307772 |
2015 |
32 |
Complex lymphatic anomalies.
61
|
Trenor CC...Chaudry G
|
25241096 |
2014 |
33 |
Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.
61
|
Croteau SE...Trenor CC
|
24252784 |
2014 |